Cargando…
Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development
Co-crystal innovation is an opportunity in drug development for both scientists and industry. In line with the “green pharmacy” concept for obtaining safer methods and advanced pharmaceutical products, co-crystallization is one of the most promising approaches to find novel patent drugs, including n...
Autores principales: | Nugrahani, Ilma, Parwati, Rismaya Desti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303568/ https://www.ncbi.nlm.nih.gov/pubmed/34299458 http://dx.doi.org/10.3390/molecules26144185 |
Ejemplares similares
-
The Benefits and Challenges of Antibiotics–Non-Steroidal Anti-Inflammatory Drugs Non-Covalent Reaction
por: Nugrahani, Ilma, et al.
Publicado: (2023) -
Amino Acids as the Potential Co-Former for Co-Crystal Development: A Review
por: Nugrahani, Ilma, et al.
Publicado: (2021) -
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
por: Rao, Praveen P. N., et al.
Publicado: (2010) -
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010) -
Diclofenac-proline nano-co-crystal development, characterization, in vitro dissolution and diffusion study
por: Nugrahani, Ilma, et al.
Publicado: (2020)